(Q35988815)

11 August 2017

1 reference

title

Modulation of antitumor responses by dendritic cells (English)

1 reference

11 August 2017

1 reference

Johannes Vieweg

1

1 reference

PubMed ID

15609005

11 August 2017

Andrew Jackson

series ordinal

2

1 reference

11 August 2017

1 January 2005

1 reference

Seminars in Immunopathology

11 August 2017

1 reference

11 August 2017

26

1 reference

11 August 2017

3

1 reference

11 August 2017

329-341

1 reference

https://scigraph.springernature.com/pub.10.1007/s00281-004-0175-1

11 August 2017

0 references

cites work

Synergy between tumor immunotherapy and antiangiogenic therapy

1 reference

12 December 2020

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

1 reference

12 December 2020

Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2

1 reference

12 December 2020

Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets

1 reference

12 December 2020

Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming

1 reference

12 December 2020

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

1 reference

12 December 2020

Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells

1 reference

12 December 2020

1 reference

12 December 2020

Processing and presentation of antigens by dendritic cells: implications for vaccines

1 reference

12 December 2020

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

12 December 2020

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

12 December 2020

Cell surface tumor endothelial markers are conserved in mice and humans

1 reference

12 December 2020

Expression and function of OX40 ligand on human dendritic cells

1 reference

12 December 2020

Dendritic cells in cancer immunotherapy

1 reference

12 December 2020

Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

1 reference

12 December 2020

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

12 December 2020

Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro

1 reference

12 December 2020

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

1 reference

12 December 2020

Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

1 reference

12 December 2020

Clinical applications of dendritic cell vaccination in the treatment of cancer

1 reference

12 December 2020

Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity.

1 reference

12 December 2020

Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides

1 reference

12 December 2020

The antigen dose determines T helper subset development by regulation of CD40 ligand

1 reference

12 December 2020

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

1 reference

12 December 2020

External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing

1 reference

12 December 2020

Tumors express both unique TSTA and crossprotective 44 kDa oncofetal antigen

1 reference

12 December 2020

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

1 reference

12 December 2020

Certified professionals: CD4(+)CD25(+) suppressor T cells

1 reference

12 December 2020

Cytokine induction by the immunomodulators imiquimod and S-27609

1 reference

12 December 2020

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

12 December 2020

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

1 reference

12 December 2020

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

1 reference

12 December 2020

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

1 reference

12 December 2020

Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells.

1 reference

12 December 2020

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

1 reference

12 December 2020

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma

1 reference

12 December 2020

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine

1 reference

12 December 2020

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

12 December 2020

Control of T-cell activation by CD4+ CD25+ suppressor T cells

1 reference

12 December 2020

Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity

1 reference

12 December 2020

Sensing pathogens and tuning immune responses

1 reference

12 December 2020

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

1 reference

12 December 2020

Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses

1 reference

12 December 2020

BCG immunotherapy of bladder cancer: 20 years on.

1 reference

12 December 2020

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

1 reference

12 December 2020

Tolerance, danger, and the extended family

1 reference

12 December 2020

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

1 reference

12 December 2020

Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation

1 reference

12 December 2020

Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis

1 reference

12 December 2020

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

12 December 2020

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

1 reference

12 December 2020

Induction of antitumour immunity using survivin peptide-pulsed dendritic cells in a murine lymphoma model

1 reference

12 December 2020

Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product

1 reference

12 December 2020

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

1 reference

12 December 2020

Imiquimod, a topical immune response modifier, induces migration of Langerhans cells

1 reference

12 December 2020

The role of CD4+ T cell responses in antitumor immunity

1 reference

12 December 2020

Derangement of immune responses by myeloid suppressor cells

1 reference

12 December 2020

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

12 December 2020

Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10

1 reference

12 December 2020

Nonmyeloablative stem cell transplantation for chronic myeloid leukemia

1 reference

12 December 2020

Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells.

1 reference

12 December 2020

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion

1 reference

12 December 2020

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

12 December 2020

Strategies for immunotherapy of cancer

1 reference

12 December 2020

The central role of CD4(+) T cells in the antitumor immune response

1 reference

12 December 2020

Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells

1 reference

12 December 2020

Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

1 reference

12 December 2020

Dendritic cells and the control of immunity

1 reference

12 December 2020

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

12 December 2020

Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand

1 reference

12 December 2020

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

1 reference

12 December 2020

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

1 reference

12 December 2020

Induction of tolerance by IL-10-treated dendritic cells

1 reference

12 December 2020

Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity

1 reference

12 December 2020

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.

1 reference

12 December 2020

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

12 December 2020

RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells

1 reference

12 December 2020

Lineage relationship and protective immunity of memory CD8 T cell subsets

1 reference

12 December 2020

Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth.

1 reference

12 December 2020

10.1007/S00281-004-0175-1

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15609005